Skip to main content
Caplight Logo









CC Diagnostics

CC Diagnostics

Private
GroningenHealthcare & Life Scienceshttps://cc-diagnostics.com/

Last Round

Grant

Sep 23, 2025

Total Funding Raised

$648,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CC Diagnostics is a biotechnology company that develops PCR-based diagnostic solutions for the early detection of cervical cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

cervical cancer screeningmolecular diagnosticsepigenetic DNA analysisqPCRDNA methylationdiagnostic assayliquid-based cytologyself-samplingcancer triageclinical laboratorybiomarkerliquid biopsyhome testingpathologymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CC Diagnostics Comparables

Compare CC Diagnostics with similar companies based on industry and business-model similarity.

CC Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epitype GmbH
88%
Self-screen B.V.
87%
Predica Diagnostics
85%

CC Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 23, 2025
AcceleratorMay 13, 2024
GrantMay 1, 2023
SeedJul 17, 2018
DebtJul 17, 2018

Key People

Founding team and executive leadership

Nutte van Belzen

Co-founder & Chief Medical Officer

Founding Team

Ronald Vos

Chief Executive Officer

Executive Team

CC Diagnostics Investors

Notable investors and investment history

CC Diagnostics investors
InvestorRounds
Carduso CapitalSeed
Tech4EvaAccelerator
Samenwerkingsverband Noord-NederlandGrant
Netherlands Enterprise AgencyDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 24, 2025

    Received the LIFE Science Innovation Award 2025.

  • Sep 23, 2025

    $8K grant received from LIFE Cooperative.

CC Diagnostics Filings

Explore SEC and related filing metadata, where available.

CC Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CC Diagnostics's valuation, stock price, and market status.

Is CC Diagnostics a public or private company?

CC Diagnostics is a private company.

What is the current stock price of CC Diagnostics?

CC Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is CC Diagnostics worth (valuation)?

Valuation information for CC Diagnostics is not publicly available.

Can I buy CC Diagnostics stock?

CC Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CC Diagnostics's last funding round?

CC Diagnostics's most recent funding round was Grant on September 23, 2025.

Who are the main investors in CC Diagnostics?

Key investors in CC Diagnostics include Carduso Capital.

Will CC Diagnostics IPO soon?

No public IPO plans have been announced for CC Diagnostics.

How can I track CC Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CC Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGroningen
Employee Range10
Year Founded2016
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?